rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-10-24
|
pubmed:abstractText |
The requirement in Northern Ireland to prescribe biological agents according to National Institute for Clinical Excellence/British Society for Rheumatology (NICE/BSR) guidelines and within a fixed budget has created a waiting list for treatment that has no parallel in the Republic of Ireland. The study investigated the bearing this situation may have had on consultants' judgements in the respective areas.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1462-0324
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1407-13
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16030081-Antibodies, Monoclonal,
pubmed-meshheading:16030081-Antirheumatic Agents,
pubmed-meshheading:16030081-Arthritis, Rheumatoid,
pubmed-meshheading:16030081-Attitude of Health Personnel,
pubmed-meshheading:16030081-Drug Utilization,
pubmed-meshheading:16030081-Focus Groups,
pubmed-meshheading:16030081-Health Care Rationing,
pubmed-meshheading:16030081-Humans,
pubmed-meshheading:16030081-Ireland,
pubmed-meshheading:16030081-Judgment,
pubmed-meshheading:16030081-Medical Staff, Hospital,
pubmed-meshheading:16030081-Northern Ireland,
pubmed-meshheading:16030081-Physician's Practice Patterns,
pubmed-meshheading:16030081-Practice Guidelines as Topic,
pubmed-meshheading:16030081-Rheumatology,
pubmed-meshheading:16030081-Treatment Outcome,
pubmed-meshheading:16030081-Tumor Necrosis Factor-alpha,
pubmed-meshheading:16030081-Waiting Lists
|
pubmed:year |
2005
|
pubmed:articleTitle |
Rheumatologists' judgements about the efficacy of anti-TNF therapy in two neighbouring regions.
|
pubmed:affiliation |
Department of Epidemiology and Public Health, Queen's University of Belfast, Belfast, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|